BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24751483)

  • 1. SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation.
    Wilking MJ; Singh C; Nihal M; Zhong W; Ahmad N
    Arch Biochem Biophys; 2014 Dec; 563():94-100. PubMed ID: 24751483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel downstream molecular targets of SIRT1 in melanoma: a quantitative proteomics approach.
    Singh CK; George J; Nihal M; Sabat G; Kumar R; Ahmad N
    Oncotarget; 2014 Apr; 5(7):1987-99. PubMed ID: 24743044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.
    Nihal M; Ahmad N; Wood GS
    Cell Cycle; 2014; 13(4):632-40. PubMed ID: 24343700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner.
    McCarthy AR; Sachweh MC; Higgins M; Campbell J; Drummond CJ; van Leeuwen IM; Pirrie L; Ladds MJ; Westwood NJ; Laín S
    Mol Cancer Ther; 2013 Apr; 12(4):352-60. PubMed ID: 23322738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
    Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
    PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.
    Dai W; Zhou J; Jin B; Pan J
    Sci Rep; 2016 Mar; 6():22622. PubMed ID: 26940009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
    Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
    Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
    Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
    BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 knockdown up-regulates p53 and p21/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner.
    Fujino T; Yokokawa R; Oshima T; Hayakawa M
    J Toxicol Sci; 2018; 43(12):711-715. PubMed ID: 30518708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation.
    Hirai S; Endo S; Saito R; Hirose M; Ueno T; Suzuki H; Yamato K; Abei M; Hyodo I
    PLoS One; 2014; 9(7):e102831. PubMed ID: 25033286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.
    George J; Nihal M; Singh CK; Ahmad N
    Mol Carcinog; 2019 Oct; 58(10):1876-1885. PubMed ID: 31292999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell line.
    Marx C; Marx-Blümel L; Lindig N; Thierbach R; Hoelzer D; Becker S; Wittig S; Lehmann R; Slevogt H; Heinzel T; Wang ZQ; Beck JF; Sonnemann J
    Invest New Drugs; 2018 Jun; 36(3):396-406. PubMed ID: 29150734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.
    Chen L; Ahmad N; Liu X
    Cell Cycle; 2016; 15(6):840-9. PubMed ID: 26900800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein.
    Prasad R; Katiyar SK
    Oncotarget; 2014 Nov; 5(21):10636-49. PubMed ID: 25361006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
    Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.
    Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH
    J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53.
    Ghosh A; Sengupta A; Seerapu GPK; Nakhi A; Shivaji Ramarao EVV; Bung N; Bulusu G; Pal M; Haldar D
    Biochem Biophys Res Commun; 2017 Jul; 488(3):562-569. PubMed ID: 28526414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human Melanoma.
    George J; Nihal M; Singh CK; Zhong W; Liu X; Ahmad N
    J Invest Dermatol; 2016 Apr; 136(4):809-818. PubMed ID: 26743598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
    Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
    Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.